Cero Therapeutics amends SRX Health promissory note, lifts borrowing capacity to $1.41 million

SRx Health Solutions Inc.
CERo Therapeutics Holdings, Inc. - Common Stock

SRx Health Solutions Inc.

SRXH

0.00

CERo Therapeutics Holdings, Inc. - Common Stock

CERO

0.00
  • Cero Therapeutics entered an amended and restated promissory note with SRX Health Solutions on June 23, 2026, increasing total borrowings to USD 1.41 million.
  • USD 663,600 of new funding closed June 23, 2026, on top of USD 750,000 funded under the original May 28, 2026 note.
  • Note carries 10% annual interest, matures May 28, 2027.
  • Lender can convert principal and interest into common stock at the lower of USD 0.05 or 80% of a 20-day pricing formula.
  • Company plans to file an SEC resale registration statement covering shares issuable on conversion; 4.99% beneficial ownership cap applies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cero Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072602), on June 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.